1-anilino-8-naphthalenesulfonate and B16 Melanoma studies

1-anilino-8-naphthalenesulfonate and B16 Melanoma

1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.

Research Excerpts

Excerpt	Relevance	Reference
"Cachexia is a multifactorial wasting syndrome most common in patients with cancer that is characterized by the uncontrolled loss of adipose and muscle mass."	1.37	Adipose triglyceride lipase contributes to cancer-associated cachexia. ( Das, SK; Diwoky, C; Eder, S; Gorkiewicz, G; Guertl, B; Haemmerle, G; Hoefler, G; Kumari, P; Schauer, S; Tamilarasan, KP; Temmel, H; Trauner, M; Vesely, P; Zechner, R; Zimmermann, R, 2011)

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

0 (0.00)

29.6817

2010's

2 (66.67)

24.3611

2020's

1 (33.33)

2.80

Authors

Authors	Studies
Shin, JA	1
Sun, M	1
Jeong, JM	1
Das, SK	1
Eder, S	1
Schauer, S	1
Diwoky, C	1
Temmel, H	1
Guertl, B	1
Gorkiewicz, G	1
Tamilarasan, KP	1
Kumari, P	1
Trauner, M	1
Zimmermann, R	1
Vesely, P	1
Haemmerle, G	1
Zechner, R	1
Hoefler, G	1
Arner, P	1

Studies

Shin, JA

Sun, M

Jeong, JM

Das, SK

Eder, S

Schauer, S

Diwoky, C

Temmel, H

Guertl, B

Gorkiewicz, G

Tamilarasan, KP

Kumari, P

Trauner, M

Zimmermann, R

Vesely, P

Haemmerle, G

Zechner, R

Hoefler, G

Arner, P

Clinical Trials (1)

Trial Overview

Trial	Phase	Enrollment	Study Type	Start Date	Status
Biochemical and Functional Biomarkers of Cachexia in Cancer Patients[NCT03191955]		120 participants (Anticipated)	Observational	2015-11-30	Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial

Phase

Enrollment

Study Type

Start Date

Status

Biochemical and Functional Biomarkers of Cachexia in Cancer Patients[NCT03191955]

120 participants (Anticipated)

Observational

2015-11-30

Recruiting

[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for 1-anilino-8-naphthalenesulfonate and B16 Melanoma

Article	Year
Borage Oil Treated with Immobilized Lipase Inhibits Melanogenesis. Lipids, 2020, Volume: 55, Issue:6 Topics: Camellia; Double-Blind Method; Enzymes, Immobilized; Fatty Acids, Nonesterified; Female; gamma-Linol	2020

Article

Year

Borage Oil Treated with Immobilized Lipase Inhibits Melanogenesis.

Lipids, 2020, Volume: 55, Issue:6

Topics: Camellia; Double-Blind Method; Enzymes, Immobilized; Fatty Acids, Nonesterified; Female; gamma-Linol

2020

Other Studies

2 other studies available for 1-anilino-8-naphthalenesulfonate and B16 Melanoma

Article	Year
Adipose triglyceride lipase contributes to cancer-associated cachexia. Science (New York, N.Y.), 2011, Jul-08, Volume: 333, Issue:6039 Topics: Adipose Tissue, White; Animals; Blood Glucose; Body Mass Index; Body Weight; Cachexia; Cytokines; Fa	2011
Medicine. Lipases in cachexia. Science (New York, N.Y.), 2011, Jul-08, Volume: 333, Issue:6039 Topics: Adipocytes; Adipose Tissue; Animals; Cachexia; Humans; Lipase; Lipolysis; Lung Neoplasms; Melanoma,	2011

Article

Year

Adipose triglyceride lipase contributes to cancer-associated cachexia.

Science (New York, N.Y.), 2011, Jul-08, Volume: 333, Issue:6039

Topics: Adipose Tissue, White; Animals; Blood Glucose; Body Mass Index; Body Weight; Cachexia; Cytokines; Fa

2011

Medicine. Lipases in cachexia.

Science (New York, N.Y.), 2011, Jul-08, Volume: 333, Issue:6039

Topics: Adipocytes; Adipose Tissue; Animals; Cachexia; Humans; Lipase; Lipolysis; Lung Neoplasms; Melanoma,

2011